tiprankstipranks
STELLA PHARMA CORPORATION (JP:4888)
:4888
Japanese Market
4888
STELLA PHARMA CORPORATION
RESEARCH TOOLSreports

STELLA PHARMA CORPORATION (4888) Financial Statements

0 Followers

STELLA PHARMA CORPORATION Financial Overview

STELLA PHARMA CORPORATION's market cap is currently ¥19.98B. The company's EPS TTM is ¥-6; its P/E ratio is -8.45; STELLA PHARMA CORPORATION is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 961.06M¥ 269.49M¥ 229.07M¥ 100.10M¥ 205.97M
Gross Profit¥ 828.72M¥ 203.69M¥ 192.36M¥ 50.73M¥ 165.24M
Operating Income¥ -90.25M¥ -760.30M¥ -806.77M¥ -741.90M¥ -680.57M
EBITDA¥ -55.52M¥ -725.26M¥ -771.73M¥ -707.77M¥ -649.12M
Net Income¥ -140.81M¥ -763.75M¥ -778.82M¥ -767.72M¥ -659.24M
Balance Sheet
Cash & Short-Term Investments¥ 3.21B¥ 2.35B¥ 2.71B¥ 3.28B¥ 1.25B
Total Assets¥ 5.42B¥ 3.82B¥ 4.33B¥ 4.72B¥ 2.05B
Total Debt¥ 766.78M¥ 933.30M¥ 1.09B¥ 1.25B¥ 1.41B
Net Debt¥ -2.44B¥ -1.12B¥ -1.62B¥ -2.02B¥ 162.05M
Total Liabilities¥ 2.21B¥ 1.44B¥ 1.58B¥ 1.64B¥ 1.82B
Stockholders' Equity¥ 3.21B¥ 2.38B¥ 2.75B¥ 3.08B¥ 230.72M
Cash Flow
Free Cash Flow¥ 136.50M¥ -887.82M¥ -853.07M¥ -1.13B¥ -793.58M
Operating Cash Flow¥ 140.41M¥ -876.84M¥ -827.67M¥ -1.08B¥ -772.81M
Investing Cash Flow¥ 287.58M¥ -9.01M¥ -29.93M¥ -350.56M¥ -22.86M
Financing Cash Flow¥ 725.78M¥ 228.25M¥ 291.69M¥ 3.46B¥ 39.92M
Currency in JPY

STELLA PHARMA CORPORATION Earnings and Revenue History

Income Statement >

STELLA PHARMA CORPORATION Debt to Assets

Balance Sheet >

STELLA PHARMA CORPORATION Cash Flow

Cash Flow >

STELLA PHARMA CORPORATION Forecast EPS vs Actual EPS

Earnings >